A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA
The latency-associated nuclear antigen (LANA) encoded by orf73 of Kaposi's sarcoma-associated herpesvirus (KSHV) binds to viral episomal DNA and nuclear heterochromatin in infected cells. A 3·2 kb transcript in KSHV-positive primary effusion lymphoma (PEL) cells (BCP-1 and BC-3) encoding a C-terminal truncated form of LANA (LANA-Δ76) has been identified. This transcript has the addition of a poly(A) tail at nt 3264 of orf73 resulting in an in-frame stop codon (TAA) effectively truncating LANA by 76 aa (∼8 kDa). Examination of the coding region revealed the presence of a non-canonical polyadenylation signal (AGTAAA) 17 nt upstream of the poly(A) tail. The protein expressed from this transcript is representative of the faster migration of the LANA doublet bands observed by SDS-PAGE and Western blot. Mutation of the poly(A) signal from AGTAAA to TGTACA produced a protein that co-migrated with the larger LANA isoform. A C-terminal LANA-Δ76 EGFP fusion protein localized to the nucleus but did not co-localize with endogenous LANA in BCP-1 cells, or heterochromatin in HEK293 cells. Using an electrophoretic mobility shift assay (EMSA), the authors were able to show that LANA-Δ76 does not bind to the KSHV terminal repeat motif known to interact with LANA. These data provide evidence for the presence of an isoform of LANA that may perform alternative functions in KSHV-infected cells.
AnJ.,
LichtensteinA. K.,
BrentG.,
RettigM. B.2002; The Kaposi sarcoma-associated herpesvirus (KSHV) induces cellular interleukin 6 expression: role of the KSHV latency-associated nuclear antigen and the AP1 response element. Blood 99:649–654[CrossRef]
BallestasM. E.,
ChatisP. A.,
KayeK. M.1999; Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science 284:641–644[CrossRef]
BoshoffC.,
GaoS. J.,
HealyL. E.10 other authors1998; Establishing a KSHV+ cell line (BCP-1) from peripheral blood and characterizing its growth in Nod/SCID mice. Blood 91:1671–1679
CaronH.,
van SchaikB.,
van der MeeM.10 other authors2001; The human transcriptome map: clustering of highly expressed genes in chromosomal domains. Science 291:1289–1292[CrossRef]
CesarmanE.,
ChangY.,
MooreP. S.,
SaidJ. W.,
KnowlesD. M.1995a; Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332:1186–1191[CrossRef]
CesarmanE.,
MooreP. S.,
RaoP. H.,
InghiramiG.,
KnowlesD. M.,
ChangY.1995b; In vitro establishment and characterization of two acquired immunodeficiency syndrome-related lymphoma cell lines (BC-1 and BC-2) containing Kaposi's sarcoma-associated herpesvirus-like (KSHV) DNA sequences. Blood 86:2708–2714
CesarmanE.,
NadorR. G.,
AozasaK.,
DelsolG.,
SaidJ. W.,
KnowlesD. M.1996; Kaposi's sarcoma-associated herpesvirus in non-AIDS related lymphomas occurring in body cavities. Am J Pathol 149:53–57
DittmerD. P.2003; Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res 63:2010–2015
GaoS. J.,
KingsleyL.,
HooverD. R.8 other authors1996a; Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med 335:233–241[CrossRef]
GaoS. J.,
KingsleyL.,
LiM.10 other authors1996b; KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 2:925–928[CrossRef]
GarberA. C.,
ShuM. A.,
HuJ.,
RenneR.2001; DNA binding and modulation of gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 75:7882–7892[CrossRef]
GarberA. C.,
HuJ.,
RenneR.2002; Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication. J Biol Chem 277:27401–27411[CrossRef]
GrahamF. L.,
SmileyJ.,
RussellW. C.,
NairnR.1977; Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36:59–74[CrossRef]
HusainS. M.,
UsherwoodE. J.,
DysonH.,
ColecloughC.,
CoppolaM. A.,
WoodlandD. L.,
BlackmanM. A.,
StewartJ. P.,
SampleJ. T.1999; Murine gammaherpesvirus M2 gene is latency-associated and its protein a target for CD8(+) T lymphocytes. Proc Natl Acad Sci U S A 96:7508–7513[CrossRef]
KedesD. H.,
OperskalskiE.,
BuschM.,
KohnR.,
FloodJ.,
GanemD.1996; The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 2:918–924[CrossRef]
KedesD. H.,
LagunoffM.,
RenneR.,
GanemD.1997; Identification of the gene encoding the major latency-associated nuclear antigen of the Kaposi's sarcoma-associated herpesvirus. J Clin Invest 100:2606–2610[CrossRef]
KellamP.,
BoshoffC.,
WhitbyD.,
MatthewsS.,
WeissR. A.,
TalbotS. J.1997; Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol 1:19–29
KrithivasA.,
YoungD. B.,
LiaoG.,
GreeneD.,
HaywardS. D.2000; Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein–Barr virus gene expression in dually infected PEL cells. J Virol 74:9637–9645[CrossRef]
LennetteE. T.,
BlackbournD. J.,
LevyJ. A.1996; Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 348:858–861[CrossRef]
PiolotT.,
TramierM.,
CoppeyM.,
NicolasJ. C.,
MarechalV.2001; Close but distinct regions of human herpesvirus 8 latency-associated nuclear antigen 1 are responsible for nuclear targeting and binding to human mitotic chromosomes. J Virol 75:3948–3959[CrossRef]
PlattG. M.,
SimpsonG. R.,
MittnachtS.,
SchulzT. F.1999; Latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts with RING3, a homolog of the Drosophila female sterile homeotic (fsh) gene. J Virol 73:9789–9795
RadkovS. A.,
KellamP.,
BoshoffC.2000; The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 6:1121–1127[CrossRef]
RainbowL.,
PlattG. M.,
SimpsonG. R.,
SaridR.,
GaoS. J.,
StoiberH.,
HerringtonC. S.,
MooreP. S.,
SchulzT. F.1997; The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 71:5915–5921
RussoJ. J.,
BohenzkyR. A.,
ChienM. C.8 other authors1996; Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A 93:14862–14867[CrossRef]
TalbotS. J.,
WeissR. A.,
KellamP.,
BoshoffC.1999; Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 257:84–94[CrossRef]
Viejo-BorbollaA.,
KatiE.,
SheldonJ. A.,
NathanK.,
MattssonK.,
SzekelyL.,
SchulzT. F.2003; A domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol 77:7093–7100[CrossRef]
WakelingM. N.,
RoyD. J.,
NashA. A.,
StewartJ. P.2001; Characterization of the murine gammaherpesvirus 68 ORF74 product: a novel oncogenic G protein-coupled receptor. J Gen Virol 82:1187–1197
A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA